Other

Cash received from option exercises

Roivant Sciences Cash received from option exercises decreased by 56.9% to $51.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 306.5%, from $12.59M to $51.19M. Over 4 years (FY 2021 to FY 2025), Cash received from option exercises shows an upward trend with a 405.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2025May 20, 2026

How to read this metric

Higher proceeds indicate active participation in equity incentive plans, which can signal employee confidence in the company's future stock performance.

Detailed definition

Cash received by the company from employees or directors exercising their vested stock options. This reflects the liquid...

Peer comparison

Common in companies with significant stock-based compensation; varies based on stock price performance relative to exercise prices.

Metric ID: other_proceeds_from_stock_options_exercised

Historical Data

20 periods
 Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$412.00K$0.00$0.00$569.00K$2.25M$21.03M$21.11M$8.88M$3.29M$2.27M$6.62M$28.12M$12.59M$30.06M$68.29M$118.81M$51.19M
QoQ Change-100.0%+294.6%+836.7%+0.4%-57.9%-62.9%-31.0%+191.5%+324.7%-55.2%+138.7%+127.2%+74.0%-56.9%
YoY Change+444.9%>999%+46.6%-89.2%-68.6%+216.6%+282.6%>999%+931.6%+322.6%+306.5%
Range$0.00$118.81M
Avg YoY Growth+461.6%
Median YoY Growth+306.5%

Cash received from option exercises at Other Companies

Frequently Asked Questions

What is Roivant Sciences's cash received from option exercises?
Roivant Sciences (ROIV) reported cash received from option exercises of $51.19M in Q1 2026.
How has Roivant Sciences's cash received from option exercises changed year-over-year?
Roivant Sciences's cash received from option exercises increased by 306.5% year-over-year, from $12.59M to $51.19M.
What is the long-term trend for Roivant Sciences's cash received from option exercises?
Over 4 years (2021 to 2025), Roivant Sciences's cash received from option exercises has grown at a 405.2% compound annual growth rate (CAGR), from $412.00K to $268.35M.
What does cash received from option exercises mean?
Cash inflow resulting from employees purchasing company stock through option plans.